产生的人类补充因子H与修饰的甘氨酸具有延长的半衰期和改善的生物活性
Todor Tschongov1, Swagata Konwar1, Andreas Busch2
1Department of Internal Medicine IV (Nephrology), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Frontiers in immunology
|May 27, 2024
概括
一种由产生的新型人体H因子 (FH) 模拟物,CPV-104,为补体相关疾病提供了有前途的治疗方法. 这种再平衡疗法在临床前模型中显示出改善的药理动力学和疗效,可能会彻底改变补充级联调节.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的补充系统药物抑制路径,可能破坏正常功能.
- 用H因子 (FH) 进行系统性治疗因生产成本和安全问题而受到限制.
- 重组FH表达在实现正确的折叠和功能方面面临着挑战.
研究的目的:
- 开发一种功能性,系统性可行的重组人因子H (FH) 模拟.
- 改进以前开发的来自的FH变体 (CPV-101) 的药理动力学特征.
- 评估修改后的FH模拟物 (CPV-104) 在补充相关疾病中的治疗潜力.
主要方法:
- 设计了一种基于的表达系统,用于重组FH生产.
- 修改了FH变种CPV-101的糖化,从而产生CPV-104.
- 在缺乏FH的小鼠中评估了药理动力学特征,体外和体外功能以及体内疗效.
主要成果:
- CPV-104表现出与原生人类FH相似的药理学特征.
- 在小鼠中,用CPV-104治疗使血清C3水平正常化,并减少脏C3沉积.
- 在in vitro和患者衍生的ex vivo试验中,CPV-104的功能与血清衍生的FH具有可比性.
结论:
- 来自的复合人类FH模拟CPV-104是一种可行的治疗候选者.
- CPV-104重新平衡补充级联,提供抑制的替代方案.
- 这种方法有望治疗与补充相关的人类疾病,如非典型的血溶性尿素性综合征和C3球病.
更多相关视频
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:05Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
01:25Protein Glycosylation
6.9K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.9K